Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats

Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats

Background The present study was designed to evaluate serum lipid profile and tumor necrosis factor-alpha (TNF-ɑ) level in diabetic rats at implantation time. Type 2 diabetes mellitus (T2DM) could affect various systems, including innate immune system and it causes chronic low-grade inflammation, in...

Full description

Bibliographic Details
Main Authors:	Abbas Bakhteyari, Parvaneh Nikpour, Fatemah Sadat Mostafavi, Nahid Eskandari, Mohammad Matinfar, Sara Soleimani Asl, Roshanak Aboutorabi
Format:	Article
Language:	English
Published:	Royan Institute (ACECR), Tehran 2019-07-01
Series:	International Journal of Fertility and Sterility
Subjects:	diabetes mellitus embryo implantation metformin pioglitazone tumor necrosis factor alpha
Online Access:	http://www.ijfs.ir/article_45540_1cd34349c0ba8a4d26e56eecb65ff422.pdf

Similar Items

Diabetes mellitus increased integrins gene expression in rat endometrium at the time of embryo implantation
by: Abbas Bakhteyari, et al.
Published: (2019-06-01)

Combined pioglitazone–metformin and clomiphene citrate versus metformin and clomiphene citrate in induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome
by: Ghada Abdel Fattah, et al.
Published: (2014-03-01)

Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
by: Jieying Liu, et al.
Published: (2023-07-01)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
by: Karoon Shahebrahimi, et al.
Published: (2016-01-01)

Evaluation of Muc1 Gene Expression at The Time of Implantation in Diabetic Rat Models Treated with Insulin, Metformin and Pioglitazone in The Normal Cycle and Ovulation Induction Cycle
by: Ronak Zarei, et al.
Published: (2020-10-01)

Metformin and Pioglitazone Reduce Gene Expression of Inflammatory Factors in Insulin Resistant and Hypertrophied Adipocytes
by: Zahra Malekpour-Dehkordi, et al.
Published: (2020-12-01)

Evaluation of Osteopontin Gene Expression in Endometrium of Diabetic Rat Models Treated with Metformin and Pioglitazone
by: Zeinab Sadat Hosseiny, et al.
Published: (2019-01-01)

Evaluation of the Clinical use of Metformin or Pioglitazone in Combination with Meloxicam in Patients with Knee Osteoarthritis; using Knee Injury and Osteoarthritis outcome Score
by: Mohammed M. Mohammed, et al.
Published: (2017-02-01)

Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
by: Mehran Mesgari Abbasi, et al.
Published: (2016-01-01)

A Histomorphological Comparative Effects of Metformin, Pioglitazone, Repaglinide and Acarbose on Polycystic Ovary in Mice
by: fariba noori, et al.
Published: (2020-04-01)

A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
by: Roselle Arbas, et al.
Published: (2024-01-01)

Effects of Pioglitazone and Metformin on Insulin Resistance Reduction in Polycystic Ovary Syndrome: A Comparative Study
by: Amir Ziaie, et al.
Published: (2012-03-01)

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
by: Dongmei Wang, et al.
Published: (2022-10-01)

The Effect of Endometrial Cell Culture on α3 and β1 integrin Genes and Protein Expression in Type 2 Diabetic Rats at The Time of Implantation
by: Fatemah Sadat Mostafavi, et al.
Published: (2022-01-01)

Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study
by: Sun R, et al.
Published: (2023-09-01)

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
by: Young Ki Lee, et al.
Published: (2013-12-01)

A Comparison of the Therapeutic Effects of Metformin, Pioglitazone and Vitamin E in Patients with Non-Alcoholic Fatty Liver
by: K Shahebrahimi, et al.
Published: (2017-09-01)

Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial
by: Han Zhao, et al.
Published: (2024-02-01)

Development of Capillary Zone Electrophoresis Method for the Simultaneous Separation and Quantification of Metformin and Pioglitazone in Dosage Forms; and Comparison with HPLC Method
by: Maymonah K. I. AlThikrallah, et al.
Published: (2023-01-01)

Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial
by: Mondal Aashish, et al.
Published: (2024-02-01)

Evaluation of vascular endothelial growth factor A and leukemia inhibitory factor expressions at the time of implantation in diabetic rats following treatment with Metformin and Pioglitazone
by: Ronak Zarei, et al.
Published: (2020-09-01)

Clomiphene citrate alone, in combination with metformin or in combination with pioglitazone as first line therapy in induction of ovulation in infertile women with polycystic ovary syndrome, a randomized controlled trial
by: Wessam Magdi Abuelghar, et al.
Published: (2013-09-01)

Pioglitazone: A boon we know less about
by: Dilip Gude
Published: (2013-01-01)

Determination of Pioglitazone Hydrochloride in Tablets by High-Performance Liquid Chromatography
by: AMR Lotfy Saber
Published: (2008-12-01)

Comparison of efficacy of add-on therapy of vildagliptin versus pioglitazone among Type 2 Diabetes Mellitus patients inadequately controlled on dual therapy of metformin plus sulfonylurea
by: Kirandeep Kaur
Published: (2014-02-01)

Pioglitazone: Indian perspective
by: Rishi Shukla, et al.
Published: (2011-01-01)

Comparative Effect of Insulin Sensitizers and Statin on Metabolic Profile and Ultrasonographical Score in Non Alcoholic Fatty Liver Disease
by: Himanshu Rana, et al.
Published: (2016-08-01)

Evaluation of Diabetes Effects on the Expression of Leukemia Inhibitory Factor and Vascular Endothelial Growth Factor A Genes and Proteins at the Time of Endometrial Receptivity after Superovulation in Rat Model
by: Ronak Zarei, et al.
Published: (2019-01-01)

Pioglitazone use and the risk of bladder cancer
by: Hsin-Wei Kuo, et al.
Published: (2014-02-01)

A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population
by: V Balaji, et al.
Published: (2014-01-01)

Formulation and evaluation of bilayer tablet by using melt granulation technique for treatment of diabetes mellitus
by: Dhruvita Patel, et al.
Published: (2012-01-01)

Effect of the antidiabetic agent pioglitazone on bone metabolism in rats
by: Junkichi Kanda, et al.
Published: (2017-09-01)

Effect of pioglitazone treatment on serum chemerin and vaspin levels in polycystic ovary syndrome.
by: Rana Hussein Kutaif, et al.
Published: (2022-04-01)

Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice
by: Lea Helena Kunze, et al.
Published: (2023-06-01)

Effect of Pioglitazone on Plasma Levels of Phenytoin in Rats
by: Hamed Ghavimi, et al.
Published: (2013-10-01)

Effect of Pioglitazone on Plasma Levels of Phenytoin in Rats
by: Abolghasem Jouyban, et al.
Published: (2013-10-01)

Anticonvulsive and Antioxidant Effects of Pioglitazone on Pilocarpine-induced Seizures in Mice
by: Saba Rostamian, et al.
Published: (2021-10-01)

Liquid Chromatographic Determination of Pioglitazone in Pharmaceuticals, Serum and Urine Samples
by: Shahnaz Perveen, et al.
Published: (2011-12-01)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
by: Marit de Jong, et al.
Published: (2017-10-01)

Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma Models
by: Huilan Zeng, et al.
Published: (2022-02-01)